Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 May 11;7(5):e015424.
doi: 10.1136/bmjopen-2016-015424.

Estimating the prevalence, hospitalisation and mortality from type 2 diabetes mellitus in Nigeria: a systematic review and meta-analysis

Davies Adeloye  1   2 , Janet O Ige  3 , Adewale V Aderemi  4 , Ngozi Adeleye  5 , Emmanuel O Amoo  1 , Asa Auta  6 , Gbolahan Oni  1
Affiliations
Meta-Analysis

Estimating the prevalence, hospitalisation and mortality from type 2 diabetes mellitus in Nigeria: a systematic review and meta-analysis

Davies Adeloye et al. BMJ Open. .

Abstract

Background: There is not yet a comprehensive evidence-based epidemiological report on type 2 diabetes mellitus (T2DM) in Nigeria. We aimed to estimate country-wide and zonal prevalence, hospitalisation and mortality rates of T2DM in Nigeria.

Methods: We searched MEDLINE, EMBASE, Global Health, Africa Journals Online (AJOL) and Google Scholar for population and hospital-based studies on T2DM in Nigeria. We conducted a random-effects meta-analysis on extracted crude estimates, and applied a meta-regression epidemiological model, using the United Nations demographics for Nigeria in 1990 and 2015 to determine estimates of diabetes in Nigeria for the two years.

Results: 42 studies, with a total population of 91 320, met our selection criteria. Most of the studies selected were of medium quality (90.5%). The age-adjusted prevalence rates of T2DM in Nigeria among persons aged 20-79 years increased from 2.0% (95% CI 1.9% to 2.1%) in 1990 to 5.7% (95% CI 5.5% to 5.8%) in 2015, accounting for over 874 000 and 4.7 million cases, respectively. The pooled prevalence rate of impaired glucose tolerance was 10.0% (95% CI 4.5% to 15.6%), while impaired fasting glucose was 5.8% (95% CI 3.8% to 7.8%). Hospital admission rate for T2DM was 222.6 (95% CI 133.1 to 312.1) per 100 000 population with hyperglycaemic emergencies, diabetic foot and cardiovascular diseases being most common complications. The overall mortality rate was 30.2 (95% CI 14.6 to 45.8) per 100 000 population, with a case fatality rate of 22.0% (95% CI 8.0% to 36.0%).

Conclusion: Our findings suggest an increasing burden of T2DM in Nigeria with many persons currently undiagnosed, and few known cases on treatment.

Keywords: Nigeria; complications; diabetes; epidemiology; mortality; prevalence.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flow chart of selection of T2DM studies in Nigeria. AJOL, Africa Journals Online; T2DM, type 2 diabetes mellitus.
Figure 2
Figure 2
Funnel plot showing distribution of selected studies. T2DM, type 2 diabetes mellitus.
Figure 3
Figure 3
Pooled prevalence rate of T2DM in Nigeria.T2DM, type 2 diabetes mellitus.
Figure 4
Figure 4
Pooled prevalence rate of IGT in Nigeria. IGT, impaired glucose tolerance.
Figure 5
Figure 5
Pooled prevalence rate of IFG in Nigeria. IFG, impaired fasting glucose.
Figure 6
Figure 6
Pooled mean FPG concentration in Nigeria. FPG, fasting plasma glucose.
Figure 7
Figure 7
Meta-regression epidemiological modelling showing relationship between prevalence of T2DM and mean age of the population.T2DM, type 2 diabetes mellitus.Note: T2DM prevalence (y), age (x), year (z) and size of the bubble correspond to study sample size. Coefficients of ‘x’ and ‘z’ are ‘0.0899’ and ‘0.125’ for the meta-regressed line, with an intercept of ‘−251’.
See this image and copyright information in PMC

References

    1. International Diabetes Federation. Diabetes Atlas. 1st ed Brussels, Belgium: International Diabetes Federation, 2000.
    1. International Diabetes Federation. Diabetes Atlas. 2nd ed Belgium: International Diabetes Federation, 2003.
    1. International Diabetes Federation. Diabetes Atlas. 3rd ed Belgium: International Diabetes Federation, 2006.
    1. Whiting DR, Guariguata L, Weil C, et al. . IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311–21.10.1016/j.diabres.2011.10.029 - DOI - PubMed
    1. International Diabetes Federation. Diabetes Atlas. 4th ed Belgium: International Diabetes Federation, 2009.

MeSH terms